Keyphrases
Heart Failure
90%
Heart Failure with Preserved Ejection Fraction (HFpEF)
89%
Patients with Heart Failure
45%
Spironolactone
29%
Confidence Interval
26%
Hazard Ratio
25%
Cardiac Function
24%
Heart Failure Hospitalization
24%
TOPCAT Trial
23%
Chronic Heart Failure
22%
Cardiovascular Mortality
19%
TOPCAT
19%
Aldosterone Antagonists
18%
Adverse Outcomes
17%
Ventricular Assist Device
17%
Dilated Cardiomyopathy
16%
Clinical Outcomes
15%
Ejection Fraction
14%
Left Ventricular Ejection Fraction
13%
Acute Decompensated Heart Failure
12%
Preserved Ejection Fraction
11%
Precision Medicine
10%
Older Adults
10%
COVID-19
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Prognostic Importance
10%
Advanced Heart Failure Therapies
9%
All-cause Mortality
9%
Placebo
9%
Heart Transplant
8%
Heart Failure Patients
8%
Atrial Fibrillation
8%
Frailty
8%
Left Ventricular Assist Device
8%
Heart Rate
8%
Clinical Trials
7%
Cardiac Structure
7%
Aborted Cardiac Arrest
7%
Vericiguat
7%
PARAGON-HF
7%
Influenza Vaccination
7%
Affordable Care Act Medicaid Expansion
7%
Readmission
7%
White People
7%
B-type Natriuretic Peptide
6%
Cardiovascular Outcomes
6%
Hospitalization
6%
Proband
6%
Influenza Vaccine
6%
Diastolic Function
6%
Medicine and Dentistry
Congestive Heart Failure
100%
Heart Failure with Preserved Ejection Fraction
40%
Cardiovascular System
24%
Hazard Ratio
18%
Aldosterone Antagonist
15%
Ventricular Assist Device
14%
Adverse Outcome
13%
Heart Function
12%
Ejection Fraction
12%
Spironolactone
10%
Heart Graft
10%
Dilated Cardiomyopathy
9%
Personalized Medicine
9%
Heart Transplantation
9%
Clinical Trial
9%
Left Ventricular Assist Device
8%
Diastolic Function
8%
Quality of Life
8%
Systolic Function
8%
Diseases
8%
Brain Natriuretic Peptide
7%
Combination Therapy
7%
Systolic Heart Failure
6%
Biological Marker
6%
Decision Making
6%
Left Ventricular Hypertrophy
5%
Transplantation
5%
Echocardiography
5%
Heart Arrest
5%
Proteomics
5%
Systolic Blood Pressure
5%
Outpatient
5%
Frailty
5%